Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease
Authors
Keywords
-
Journal
JOURNAL OF NEPHROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-23
DOI
10.1007/s40620-020-00749-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy
- (2020) Devy Deliyanti et al. HYPERTENSION
- Dicarbonyl-mediated AGEing and diabetic kidney disease
- (2020) Alexandra Dimitropoulos et al. JOURNAL OF NEPHROLOGY
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- Type 2 diabetes and the kidney: Insights from cardiovascular outcome trials
- (2019) Dario Giugliano et al. DIABETES OBESITY & METABOLISM
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse
- (2019) Jay C. Jha et al. DIABETOLOGIA
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Lipoxin A4 restores oxidative stress-induced vascular endothelial cell injury and thrombosis-related factor expression by its receptor-mediated activation of Nrf2-HO-1 axis
- (2019) Songbai Yang et al. CELLULAR SIGNALLING
- A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
- (2019) CongXiao Zhang et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c
- (2019) Christopher P. Cannon et al. CIRCULATION
- A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: protocol and statistical considerations
- (2019) Anne T. Reutens et al. Contemporary Clinical Trials
- Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”
- (2019) Giuseppe Pugliese et al. JOURNAL OF NEPHROLOGY
- Semaglutide Treatment and Renal Function in the SUSTAIN 6 Trial
- (2018) TINA VILSBØLL et al. DIABETES
- NOX, NOX, Are You Here? The Emerging Role of NOX5 in Diabetic Neuropathy
- (2018) STEPHANIE EID et al. DIABETES
- Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
- (2018) M. ANGELYN BETHEL et al. DIABETES
- Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
- (2018) Yi Huang et al. EMBO Molecular Medicine
- Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
- (2018) Paul M Ridker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
- (2018) Eoin P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
- (2018) Masayuki Yamamoto et al. PHYSIOLOGICAL REVIEWS
- OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
- (2018) Carlo Marchetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
- (2018) Vlado Perkovic et al. Lancet Diabetes & Endocrinology
- A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes
- (2018) Jay C. Jha et al. CLINICAL SCIENCE
- Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis
- (2018) Raelene J. Pickering et al. JOURNAL OF CLINICAL INVESTIGATION
- Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals
- (2018) Francesca Viazzi et al. JOURNAL OF NEPHROLOGY
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
- (2018) Marcel H A Muskiet et al. Lancet Diabetes & Endocrinology
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury
- (2017) Jin Joo Cha et al. LABORATORY INVESTIGATION
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis
- (2017) Davide Bolignano et al. PLoS One
- Diabetes and Kidney Disease: Role of Oxidative Stress
- (2016) Jay C. Jha et al. ANTIOXIDANTS & REDOX SIGNALING
- Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes
- (2016) Radko Komers et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes
- (2016) M. T. Coughlan et al. CLINICAL SCIENCE
- Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
- (2016) Karly C. Sourris et al. CURRENT DRUG TARGETS
- Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease
- (2016) Melinda T. Coughlan et al. KIDNEY INTERNATIONAL
- The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/−Mice
- (2016) Weiling Leng et al. MEDIATORS OF INFLAMMATION
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular RemodelingSignificance
- (2015) Stephen P. Gray et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Nrf2 regulates ROS production by mitochondria and NADPH oxidase
- (2015) Stjepana Kovac et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy
- (2015) Jay C. Jha et al. DIABETOLOGIA
- Late-intervention study with ebselen in an experimental model of type 1 diabetic nephropathy
- (2015) S. M. Tan et al. FREE RADICAL RESEARCH
- Tofogliflozin, A Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation
- (2015) Y. Ishibashi et al. HORMONE AND METABOLIC RESEARCH
- Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease
- (2015) Y.-H. You et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
- (2015) Khurrum Shahzad et al. KIDNEY INTERNATIONAL
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease
- (2014) S. M. Tan et al. DIABETES
- Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy
- (2014) J. C. Jha et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
- (2013) Stephen P. Gray et al. CIRCULATION
- Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis
- (2013) Sayaka Maeda et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Nephropathy and Elevated BP in Mice with Podocyte-Specific NADPH Oxidase 5 Expression
- (2013) C. E. Holterman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
- (2013) Hiroki Fujita et al. KIDNEY INTERNATIONAL
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes
- (2012) Mona Sedeek et al. CLINICAL SCIENCE
- Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice
- (2012) A. M. D. Watson et al. DIABETES
- Role of Nox4 in murine models of kidney disease
- (2012) Andrea Babelova et al. FREE RADICAL BIOLOGY AND MEDICINE
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes
- (2011) Karly C. Sourris et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pyridorin in Type 2 Diabetic Nephropathy
- (2011) E. J. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse
- (2010) P. Chew et al. DIABETES
- Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy
- (2010) S. M. Tan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mechanisms of Podocyte Injury in Diabetes: Role of Cytochrome P450 and NADPH Oxidases
- (2009) A. A. Eid et al. DIABETES
- Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes: An Inception Cohort Study
- (2009) P. Hovind et al. DIABETES
- The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
- (2009) P.-H. Groop et al. DIABETES
- Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress
- (2009) Anca V. Sima et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Superoxide and Respiratory Coupling in Mitochondria of Insulin-Deficient Diabetic Rats
- (2008) Judith A. Herlein et al. ENDOCRINOLOGY
- AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats
- (2008) Philip Wenzel et al. FREE RADICAL BIOLOGY AND MEDICINE
- Calcium-Dependent NOX5 Nicotinamide Adenine Dinucleotide Phosphate Oxidase Contributes to Vascular Oxidative Stress in Human Coronary Artery Disease
- (2008) Tomasz J. Guzik et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus
- (2007) Philip Wenzel et al. ATHEROSCLEROSIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started